G E Darling
Overview
Explore the profile of G E Darling including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
21
Citations
308
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Blitz M, Butts C, Kneteman N, Bigam D, Oosthuizen J, Phang P, et al.
Can J Surg
. 2023 Jun;
45(Suppl 3):3-26.
PMID: 37381180
No abstract available.
2.
Bodie G, Hagen J, Almamar A, Majumdar S, Wang X, Tuepah R, et al.
Can J Surg
. 2022 Apr;
55(4 Suppl 1):S63-S135.
PMID: 35488395
No abstract available.
3.
Muller P, Kapp J, Vetter D, Bonavina L, Brown W, Castro S, et al.
Dis Esophagus
. 2020 Sep;
34(6).
PMID: 32960264
There are no internationally recognized criteria available to determine preparedness for hospital discharge after esophagectomy. This study aims to achieve international consensus using Delphi methodology. The expert panel consisted of...
4.
Konradsson M, van Berge Henegouwen M, Bruns C, Chaudry M, Cheong E, Cuesta M, et al.
Dis Esophagus
. 2019 Oct;
33(4).
PMID: 31608938
Delayed gastric conduit emptying (DGCE) after esophagectomy for cancer is associated with adverse outcomes and troubling symptoms. Widely accepted diagnostic criteria and a symptom grading tool for DGCE are missing....
5.
Doherty M, Leung Y, Su J, Naik H, Patel D, Eng L, et al.
Dis Esophagus
. 2018 Jun;
31(12).
PMID: 29905764
Esophageal cancer and its treatment can cause serious morbidity/toxicity. These effects on health-related quality of life (HRQOL) can be measured using disease-specific scales such as FACT-E, generic scales such as...
6.
Wakeam E, Acuna S, Leighl N, Giuliani M, Finlayson S, Varghese T, et al.
Lung Cancer
. 2017 Jun;
109:78-88.
PMID: 28577955
Background: The role of surgery in small cell lung cancer (SCLC) is controversial. Survival outcomes for resection of stage I-IIIA SCLC compared to chemotherapy-based non-surgical treatment (NST) were examined using...
7.
Wakeam E, Varghese Jr T, Leighl N, Giuliani M, Finlayson S, Darling G
Lung Cancer
. 2017 Jun;
109:117-123.
PMID: 28577940
Background: Practice guidelines from the National Comprehensive Cancer Network and the American Society of Clinical Oncology recommend pathologic mediastinal staging and surgical resection for patients with clinically node-negative T1/T2 small...
8.
Rice T, Apperson-Hansen C, DiPaola L, Semple M, Lerut T, Orringer M, et al.
Dis Esophagus
. 2016 Oct;
29(7):707-714.
PMID: 27731549
To address uncertainty of whether clinical stage groupings (cTNM) for esophageal cancer share prognostic implications with pathologic groupings after esophagectomy alone (pTNM), we report data-simple descriptions of patient characteristics, cancer...
9.
Rice T, Lerut T, Orringer M, Chen L, Hofstetter W, Smithers B, et al.
Dis Esophagus
. 2016 Oct;
29(7):715-723.
PMID: 27731548
To address uncertainty of whether pathologic stage groupings after neoadjuvant therapy (ypTNM) for esophageal cancer share prognostic implications with pathologic groupings after esophagectomy alone (pTNM), we report data-simple descriptions of...
10.
Rice T, Chen L, Hofstetter W, Smithers B, Rusch V, Wijnhoven B, et al.
Dis Esophagus
. 2016 Oct;
29(7):724-733.
PMID: 27731547
We report data-simple descriptions of patient characteristics, cancer categories, and non-risk-adjusted survival-for patients with pathologically staged cancer of the esophagus and esophagogastric junction after resection or ablation with no preoperative...